Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients
http://www.zacks.com/stock/news/431041/novo-nordisks-victoza-gets-fda-nod-for-pediatric-patients?cid=CS-ZC-FT-431041
Jun 18, 2019 - Novo Nordisk's (NVO) Victoza gets FDA approval for the treatment of pediatric patients aged 10 years or older with type II diabetes.
0
Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice
http://www.zacks.com/stock/news/430445/are-you-looking-for-a-high-growth-dividend-stock-eli-lilly-lly-could-be-a-great-choice?cid=CS-ZC-FT-430445
Jun 17, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eli Lilly (LLY) have what it takes? Let's find out.
0
Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod
http://www.zacks.com/stock/news/429560/pharma-stock-roundup-mrk-buys-small-cancer-biotech-rhhby-mrk-drugs-get-fda-nod?cid=CS-ZC-FT-429560
Jun 14, 2019 - Key developments of the week include Merck's (MRK) deal to buy Tilos Therapeutics and FDA approval for Roche's (RHHBY) polatuzumab vedotin and Merck's Keytruda.
0
Related Companies
| Name | Exchange | Price | Mkt Cap | |
| NVO | Novo Nordisk A/S | NYSE | $47.64 | $114.84B |
| SNY | Sanofi | NYSE | $43.75 | $109.14B |
| ABT | Abbott Laboratories | NYSE | $67.67 | $118.71B |
| BMY | Bristol-Myers Squibb Company | NYSE | $61.3 | $100.03B |
| GSK | GlaxoSmithKline PLC | NYSE | $39.21 | $97.25B |